Doppelgerz® V.I.P. Spermactiv

Dosage form Application area Recommendations for use Contraindications Manufacturer
Read on
Certificate number:RU.77.99.88.003.Е.005517.12.17
Date of registration and renewal:22.12.2017
Dosage form: & nbspCapsules with a mass of 1020 mg.
Classification "Composition" & nbsp BAD - products of plant, animal or mineral origin BADA - products of beekeeping
Classification "Clinical" & nbsp Supplements that support the functions of the genitourinary system BAD-source of monovitamins and vitamin-like substances Supplements containing zinc, copper, manganese Supplements containing selenium
Composition: & nbspDry root extract of Peruvian ginseng, Gotu kola extract, ginseng root extract, caffeine, alpha-tocopherol acetate, zinc oxide, sodium selenite, soybean oil, soy lecithin, beeswax.
Scope: & nbspFor sale to the population through the pharmacy network and specialized stores, the trade network departments as a biologically active food additive for men - an additional source of vitamin E, zinc and selenium, a source of caffeine, ginsenosides and phytosterols.
Suggested Usage: & nbspAdults take 1 capsule daily with meals. Duration of admission is 2-3 weeks. If necessary, the reception can be repeated.
Contraindications:Individual intolerance of components, increased nervous excitability, insomnia, high blood pressure, cardiac disorders, pronounced atherosclerosis, reception in the evening.
Special instructions:Before use, it is recommended to consult a doctor.
Shelf life:3 years.
Storage conditions:Store in a dry place inaccessible to children at a temperature not exceeding 25 ° C.
Research protocols:ATreplacing the certificate of state registration No. RU.77.99.88.003.E.000256.01.17 of 23.01.2017, the expert opinion of the Federal State Unitary Enterprise ФЦГ ФЦГ and Э Роспотребнадзора №10-2 ФЦ / 6377 of 16.11.2010, the State Veterinary and Technical Institute of the Russian Academy of Agricultural Sciences No. 3923 / 108/1, No. 3923/108/2, No. 3923/108/3 of 09.06.2014, the test report of the FBUC of the FTsG and E of Rospotrebnadzor No. 586 of May 26, 2014.
Recipient:Kvayser Pharma, Open CompanyKvayser Pharma, Open Company Russian Federation
Information update date: & nbsp02.02.2018
Instructions
Up
talkdrugs

+8 (800)555-35-35

[email protected]

The reference book of medicines of the Publishing Group "GEOTAR-Media" - the leader in the field of professional medical and pharmaceutical literature.

The information on the preparations placed on the site is intended only for specialists. Drug descriptions can not be used by patients to make an independent decision on their use.

It is forbidden to copy any instructions of medicinal products, biologically active additives or other information from the site www.talkdrugs.info without the written permission of the Publishing House "GEOTAR".

All rights reserved.© Publishing group "GEOTAR-Media" 2008-2016.